Payment of 22013 shares by Saha Saurabh of Centessa Pharmaceuticals subject to Rule 16b-3

CNTA Stock  USD 17.01  0.49  2.80%   
About 61% of Centessa Pharmaceuticals' investor base is looking to short. The analysis of the overall investor sentiment regarding Centessa Pharmaceuticals PLC suggests that many traders are alarmed. The current market sentiment, together with Centessa Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Centessa Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
  
Filed transaction by Centessa Pharmaceuticals director. Payment of exercise price or tax liability by delivering or withholding securities

Read at macroaxis.com
Centessa insider trading alert for payment of ordinary shares by Saha Saurabh, Chief Executive Officer, on 4th of April 2023. This event was filed by Centessa Pharmaceuticals with SEC on 2023-04-04. Statement of changes in beneficial ownership - SEC Form 4

Centessa Pharmaceuticals Fundamental Analysis

We analyze Centessa Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Centessa Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Centessa Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Shares Owned By Insiders

Shares Owned By Insiders Comparative Analysis

Centessa Pharmaceuticals is currently under evaluation in shares owned by insiders category among its peers. Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.

Centessa Pharmaceuticals Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Centessa Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Centessa Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Centessa Pharmaceuticals by comparing valuation metrics with similar companies.

Peers

Centessa Pharmaceuticals Related Equities

DSGNDesign Therapeutics   7.94   
0%
100.0%
CCCCC4 Therapeutics   7.10   
0%
89.0%
TRDAEntrada Therapeutics   4.87   
0%
61.0%
LRMRLarimar Therapeutics   4.24   
0%
53.0%
MLYSMineralys Therapeutics,   4.08   
0%
51.0%
CRNXCrinetics Pharmaceuticals   3.10   
0%
39.0%
IPSCCentury Therapeutics   2.97   
0%
37.0%
EWTXEdgewise Therapeutics   2.55   
0%
32.0%
CGEMCullinan Oncology   2.34   
0%
29.0%
IRONDisc Medicine   2.19   
0%
27.0%
OPTOpthea   1.90   
0%
23.0%
ERASErasca   1.48   
0%
18.0%
STROSutro Biopharma   1.04   
0%
13.0%
NUVLNuvalent   0.99   
0%
12.0%
TARSTarsus Pharmaceuticals   0.94   
0%
11.0%
GLUEMonte Rosa   0.84   
0%
10.0%
HLVXHillevax   0.48   
0%
6.0%
NAMSWNewAmsterdam Pharma   1.95   
24.0%
0%
GNFTGenfit   2.35   
29.0%
0%

Complementary Tools for Centessa Stock analysis

When running Centessa Pharmaceuticals' price analysis, check to measure Centessa Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Centessa Pharmaceuticals is operating at the current time. Most of Centessa Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Centessa Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Centessa Pharmaceuticals' price. Additionally, you may evaluate how the addition of Centessa Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Volatility Analysis
Get historical volatility and risk analysis based on latest market data